TNF and endothelial dysfunction: This is of potential interest as biomarkers of endothelial dysfunction-endothelial cell activation are elevated in patients with RA and anti-TNF blockade improved endothelial dysfunction [72] as well as decreased the levels of endothelial cell activation biomarkers [73].